Food allergy - 11/08/11
, Hugh A. Sampson, MDAbstract |
Adverse immune responses to foods affect approximately 5% of young children and 3% to 4% of adults in westernized countries and appear to have increased in prevalence. Food-induced allergic reactions are responsible for a variety of symptoms and disorders involving the skin and gastrointestinal and respiratory tracts and can be attributed to IgE-mediated and non–IgE-mediated (cellular) mechanisms. Genetic disposition and environmental factors might abrogate oral tolerance, leading to food allergy. Disease outcomes are influenced by the characteristics of the immune response and of the triggering allergen. Diagnosis is complicated by the observation that detection of food-specific IgE (sensitization) does not necessarily indicate clinical allergy. Therefore diagnosis requires a careful medical history, laboratory studies, and, in many cases, an oral food challenge to confirm a diagnosis. Novel diagnostic methods, including ones that focus on immune responses to specific food proteins or epitopes of specific proteins, are under study. Currently, management of food allergies consists of educating the patient to avoid ingesting the responsible allergen and to initiate therapy (eg, with injected epinephrine for anaphylaxis) in case of an unintended ingestion. Improved therapeutic strategies under study include oral and sublingual immunotherapy, Chinese herbal medicine, anti-IgE antibodies, and modified vaccines.
Le texte complet de cet article est disponible en PDF.Key words : Food allergy, food hypersensitivity, oral tolerance, gastrointestinal food hypersensitivity, food allergens, anaphylaxis
Abbreviations used : OFC, OIT, SPT
Plan
| Disclosure of potential conflict of interest: S. H. Sicherer is a consultant for the Food Allergy Initiative and a medical advisor for the Food Allergy & Anaphylaxis Network and has received research support from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. H. A. Sampson is a consultant for and holds shares in Allertein Pharmaceuticals, LLC; is a consultant and scientific advisor for the Food Allergy Initiative; and has received research support from the Food Allergy Initiative and the National Institutes of Health/National Institute of Allergy and Infectious Diseases. |
Vol 125 - N° 2S2
P. S116-S125 - février 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
